Vanguard Group’s BioRestorative Therapies BRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.6K | Hold |
29,730
| – | – | ﹤0.01% | 4198 |
|
|
2025
Q1 | $52.9K | Buy |
29,730
+9,258
| +45% | +$16.5K | ﹤0.01% | 4188 |
|
|
2024
Q4 | $29.3K | Hold |
20,472
| – | – | ﹤0.01% | 4239 |
|
|
2024
Q3 | $35.6K | Hold |
20,472
| – | – | ﹤0.01% | 4267 |
|
|
2024
Q2 | $41.6K | Hold |
20,472
| – | – | ﹤0.01% | 4305 |
|
|
2024
Q1 | $28.3K | Sell |
20,472
-100,161
| -83% | -$138K | ﹤0.01% | 4363 |
|
|
2023
Q4 | $210K | Sell |
120,633
-17,185
| -12% | -$29.9K | ﹤0.01% | 4217 |
|
|
2023
Q3 | $247K | Buy |
137,818
+10,862
| +9% | +$19.4K | ﹤0.01% | 4213 |
|
|
2023
Q2 | $560K | Buy |
126,956
+1,000
| +0.8% | +$4.41K | ﹤0.01% | 4087 |
|
|
2023
Q1 | $428K | Sell |
125,956
-9,090
| -7% | -$30.9K | ﹤0.01% | 4166 |
|
|
2022
Q4 | $371K | Hold |
135,046
| – | – | ﹤0.01% | 4178 |
|
|
2022
Q3 | $436K | Hold |
135,046
| – | – | ﹤0.01% | 4251 |
|
|
2022
Q2 | $398K | Hold |
135,046
| – | – | ﹤0.01% | 4341 |
|
|
2022
Q1 | $706K | Sell |
135,046
-17,408
| -11% | -$91K | ﹤0.01% | 4305 |
|
|
2021
Q4 | $662K | Buy |
+152,454
| New | +$662K | ﹤0.01% | 4370 |
|